PREFERAOB ONE- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, d-, iron sucrose, heme iron polypeptide, potassium iodide, zinc oxide, schizochytrium dha oil capsule, liquid filled
MEDA Pharmaceuticals
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
PreferaOB ONE® is a prescription prenatal/postnatal multivitamin/multimineral nutritional supplement with Omega-3 fatty acid (life’sDHA™*). PreferaOB ONE® is an oblong shaped, opaque purple colored softgel, imprinted "AP 86" in white ink on one side and plain on the other.
Each PreferaOB ONE® Softgel contains:
VITAMINS |
MINERALS |
|
|
OMEGA-3 FATTY ACID
Docosahexaenoic Acid (DHA)…………200 mg
200 mg of DHA from 500 mg of algal oil derived from Crypthecodinium cohnii.
life’sDHA™ Oil includes: DHA algal oil, high oleic sunflower oil, ascorbyl palmitate (vitamin A) & tocopherols (as antioxidants).
DHA is derived from the oils of microalgae, which is grown outside of the ocean, in a controlled environment, eliminating the risk of oceanic contamination.
Other Ingredients: Gelatin, soybean oil, yellow beeswax, lecithin, D&C red #33, FD&C blue #1, titanium dioxide and purified water.
PreferaOB ONE® is a prescription multivitamin/multimineral nutritional supplement with Omega-3 fatty acid (life’sDHA™) indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. PreferaOB ONE® is also beneficial in improving the nutritional status of women prior to conception.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Ingestion of more than 3 grams of Omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of Omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding diathesis.
WARNING
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Folic acid when administered as a single agent in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Pregnant women and nursing mothers should avoid supplemental doses of vitamin E higher than RDA amounts. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-877-999-8410 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
One softgel daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.
KEEP OUT OF REACH OF CHILDREN.
Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°-86°F).
To protect from light, dispense in carton provided. Once open, blisters should be stored in carton.
*life’sDHA™ is a trademark of Martek Biosciences Corporation, Columbia, MD.
**Proferrin® is a registered trademark of Colorado BioLabs, Inc., Cozad, NE.
© 2015 Meda Pharmaceuticals Inc.
IN-6886-05 Rev 7/2015
PREFERAOB ONE
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, d-, iron sucrose, heme iron polypeptide, potassium iodide, zinc oxide, schizochytrium dha oil capsule, liquid filled |
||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - MEDA Pharmaceuticals (051229602) |